Aurinia Pharmaceuticals Statistics
NASDAQ: AUPHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
14.70-0.19 (-1.28%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Aurinia Pharmaceuticals by the numbers
Aurinia Pharmaceuticals has a market capitalization of $1.97 billion based on 134.00M shares outstanding. Its trailing P/E ratio is 6.4, and its forward P/E is 12.7. The stock trades 10.3% below its 50-day average and 6.6% below its 200-day average.
Average daily trading volume is 858.74K shares, or about $12.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AUPH valuation vs. peer median
| Metric | AUPH | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.97B | $1.86B | +6% |
| Avg. volume | 858.74K | 1.66M | -48% |
Peer median across 8 companies: HRMY, TRVI, PVLA, BHVN, IMNM, VERA, SEPN, MRVI.
Valuation
- Market cap
- $1.97B
- P/E (TTM)
- 6.45
- Forward P/E
- 12.67
- Price / sales (latest FY)
- 6.96
- EPS (TTM)
- $2.28
- Shares outstanding
- 134.00M
Price and trading
- Previous close
- 14.89
- Open
- 14.72
- Day range
- 14.63 – 14.97
- 52-week range
- 13.52 – 19.25
- 52-week change
- -6.25%
- Beta
- —
- Volume
- 1.34M
- Average volume
- 858.74K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 30, 2026
Additional statistics
- Market Cap
- 1.97B
- Pe
- 6.45
- Forward Pe
- 12.67
- Eps
- 2.28
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 19.25
- Week52 Low
- 13.52
- Avg Volume
- 858.74K
- Shares Outstanding
- 134.00M
- Ma50
- 16.38
- Ma200
- 15.74
- Earnings Date
- Oct 30, 2026
- Pct From52w High
- -23.64%
- Pct From52w Low
- 8.73%